SLC39A12

Chr 10

solute carrier family 39 member 12

Also known as: LZT-Hs8, ZIP-12, ZIP12, bA570F3.1

SLC39A12 encodes a zinc transporter that imports zinc from the extracellular space into cells, playing a role in neurulation and neurite extension. Mutations cause autosomal recessive developmental and epileptic encephalopathy with microcephaly and growth retardation, typically presenting in early infancy. The gene is not highly constrained against loss-of-function variants.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
13
P/LP submissions
0%
P/LP missense
0.76
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySLC39A12
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 97 VUS of 128 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.76LOEUF
pLI 0.000
Z-score 2.57
OE 0.50 (0.330.76)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.29Z-score
OE missense 1.04 (0.961.14)
375 obs / 359.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.50 (0.330.76)
00.351.4
Missense OE1.04 (0.961.14)
00.61.4
Synonymous OE1.04
01.21.6
LoF obs/exp: 15 / 30.3Missense obs/exp: 375 / 359.8Syn Z: -0.39
DN
0.75top 25%
GOF
0.7030th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

128 submitted variants in ClinVar

Classification Summary

Pathogenic13
VUS97
Likely Benign6
Benign5
13
Pathogenic
97
VUS
6
Likely Benign
5
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
13
0
13
Likely Pathogenic
0
0
0
0
0
VUS
0
90
7
0
97
Likely Benign
0
5
0
1
6
Benign
0
1
4
0
5
Total096241121

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SLC39A12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗